Watch breaking news videos and read news updates about Abbott Laboratories on FOXBusiness.com.
LATEST VIDEOS
Pharma to Benefit From Health-Care Reform
10/14/2009|FOX Business
S&P's Sam Stovall argues health-care reform will benefit pharmaceuticals by increasing customers.
We break down if the government spending plan has hit the mark or missed its target.
Barron's Mike Santoli on breaks down the players who have played the rally correctly.
Ex-CBO Director on Health-Care Costs
10/12/2009|FOX Business
Fmr. Congressional Budget Office Director Douglas Holtz-Eakin on health-care reform's impact on the national debt.
We break down why the good news coming from the housing sector might not be sustainable.
Big Week for M&A, but Will it Continue?
09/29/2009|FOX Business
Levey & Co Co-Founder Claire Gruppo on the outlook for m&a activity.
Cavuto Business Report 9-28-09
09/28/2009|FOX Business
Merger mania sends stocks soaring. Meanwhile, Xerox worked out a deal to buy Affiliated Computer.
Summer Outlook for the Markets
05/26/2009|Money for Breakfast
Tim Call of The Capital Management Corp., and Dow Jones Newswires Managing Editor Neil Lipschutz on what to expect from the markets this summer.
LATEST STORIES
Abbott Laboratories Reports Positive Results on Niaspan
FOXBusiness| Markets
FOXBusiness Abbott Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan. The company said that patients who used Niaspan along
Story|11/16/2009
Merck, Abbott Rise After Study
FOXBusiness| Markets
study of cholesterol drug Zetia that showed Zetia did not combat artery clogging as well as Niaspan, made by Abbott Laboratories (ABT). However, the study found Zetia does not worsen artery-clogging. Barbara Ryan, an analyst for Deutsche
Story|11/16/2009
Large-cap Stocks Are Market's Best Value
| MarketWatch| Markets
INTC) , Microsoft Corp. (MSFT) , Corning Inc. (GLW) , Raytheon Co. (RTN) , Monsanto Co. (MON) , Abbott Laboratories (ABT) , Aetna Inc. (AET) , and "even some of the higher-quality financial names like Travelers (TRV
Story|11/11/2009
Abbott Labs Leads Drug Stocks Higher
| MarketWatch Pulse| Markets
Val Brickates Kennedy MarketWatch Pulse BOSTON -- Abbott Laboratories led drug stocks into positive territory early Wednesday as shares of the conglomerate gained in the wake of a positive third
Story|10/14/2009
Abbott Beats Estimates, Lifts Forecast
FOXBusiness| Markets
FOXBusiness Shares of Abbott Labs (ABT) rose moderately Tuesday after the drug and diagnostic tool maker reported a third- quarter profit above analysts' estimates
Story|10/14/2009
Abbott Reports 37% Spike In Third-quarter Earnings
| MarketWatch Pulse| Markets
Val Brickates Kennedy MarketWatch Pulse BOSTON -- Abbott Laboratories early Wednesday reported third-quarter net income rose 36.5% to $1.48 billion, or 95 cents a share, compared with $1
Story|10/14/2009
| FOXBusiness| Markets
the age of 61, The Wall Street Journal reported ahead of Wednesday's close. Shares of Lazard were halted pending news. Abbott Labs (ABT) reported an adjusted-profit of 92 cents a share on sales of $7.76 billion, topping analysts' views by 2 cents
Story|10/14/2009
| MarketWatch| Markets
Wednesday's session are J.P. Morgan Chase & Co., Abbott Laboratories and Host Hotels & Resorts Inc. J.P. Morgan Chase ..... according to analysts surveyed by Thomson Reuters. Abbott Laboratories (ABT) is expected to report third-quarter earnings
Story|10/13/2009
Abbott Purchases Solvay Pharma Division
FOXBusiness| Markets
Belgian pharmaceutical company, announced on Monday it is selling its drug-making division to U.S.-based Abbott Laboratories (ABT) for EUR4.5 billion in cash. Solvay plans to use the money raised from the sale to fund its growing
Story|09/28/2009
Drug Stocks Climb; Abbott Gains On Solvay Deal
| MarketWatch Pulse| Markets
Val Brickates Kennedy MarketWatch Pulse BOSTON -- Drug stocks climbed in early action Monday as shares of Abbott Laboratories gained after it announced it was buying Solvay SA's pharmaceutical unit for $6.6 billion, plus future milestone
Story|09/28/2009